Physician profile
Roderick B Meese
NPI 1336134642
$4,000.54
in general payments reported to CMS, 2019-2025
25 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $632 · 2021: $774 · 2022: $588 · 2023: $635 · 2024: $487 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $756.31 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $663.36 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $600.49 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $392.97 | 2019-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $292.84 | 2022-2025 | Verquvo, Lagevrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.54 | 2021-2024 | Jardiance |
| Amarin Pharma, INC. | $175.35 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $142.16 | 2020-2025 | Camzyos |
| Boston Scientific Corporation | $109.73 | 2019-2024 | Bodyguardian, Zoom Wireless Transmitter |
| Abiomed | $88.32 | 2025 | |
| Sanofi-Aventis U.S. LLC | $83.67 | 2019-2024 | |
| Pfizer INC. | $82.35 | 2025 | |
| Amgen INC. | $75.93 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $55.43 | 2020-2021 | |
| Recor Medical INC | $35.37 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $35.03 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $34.99 | 2024 | Opsumit, Uptravi |
| Abbott Laboratories | $30.55 | 2021-2022 | |
| Astellas Pharma US INC | $30.06 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $24.78 | 2024 | |
| Cordis US Corp. | $19.72 | 2025 | Mynx Control Venous |
| Impulse Dynamics (USA) INC. | $19.68 | 2021 | |
| Philips North America LLC | $14.40 | 2024 | (Ck4) Mcot |
| Medtronic, INC. | $12.51 | 2021 | |
| Bardy Diagnostics, INC. | $9.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Meese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.